214 related articles for article (PubMed ID: 9192303)
21. A HERG current sustains a cardiac-type action potential in neuroblastoma S cells.
D'Amico M; Biagiotti T; Fontana L; Restano-Cassulini R; Lasagna N; Arcangeli A; Wanke E; Olivotto M
Biochem Biophys Res Commun; 2003 Feb; 302(1):101-8. PubMed ID: 12593854
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of the current of heterologously expressed HERG potassium channels by imipramine and amitriptyline.
Teschemacher AG; Seward EP; Hancox JC; Witchel HJ
Br J Pharmacol; 1999 Sep; 128(2):479-85. PubMed ID: 10510461
[TBL] [Abstract][Full Text] [Related]
23. Blockade of HERG channels by the class III antiarrhythmic azimilide: mode of action.
Busch AE; Eigenberger B; Jurkiewicz NK; Salata JJ; Pica A; Suessbrich H; Lang F
Br J Pharmacol; 1998 Jan; 123(1):23-30. PubMed ID: 9484850
[TBL] [Abstract][Full Text] [Related]
24. Protein kinase A-mediated phosphorylation of HERG potassium channels in a human cell line.
Wei Z; Thomas D; Karle CA; Kathöfer S; Schenkel J; Kreye VA; Ficker E; Wible BA; Kiehn J
Chin Med J (Engl); 2002 May; 115(5):668-76. PubMed ID: 12133532
[TBL] [Abstract][Full Text] [Related]
25. Interactions of the antimalarial drug mefloquine with the human cardiac potassium channels KvLQT1/minK and HERG.
Kang J; Chen XL; Wang L; Rampe D
J Pharmacol Exp Ther; 2001 Oct; 299(1):290-6. PubMed ID: 11561091
[TBL] [Abstract][Full Text] [Related]
26. The functional properties of the human ether-à-go-go-like (HELK2) K+ channel.
Becchetti A; De Fusco M; Crociani O; Cherubini A; Restano-Cassulini R; Lecchi M; Masi A; Arcangeli A; Casari G; Wanke E
Eur J Neurosci; 2002 Aug; 16(3):415-28. PubMed ID: 12193184
[TBL] [Abstract][Full Text] [Related]
27. HERG K+ channels: friend and foe.
Vandenberg JI; Walker BD; Campbell TJ
Trends Pharmacol Sci; 2001 May; 22(5):240-6. PubMed ID: 11339975
[TBL] [Abstract][Full Text] [Related]
28. Blockade of HERG and Kv1.5 by ketoconazole.
Dumaine R; Roy ML; Brown AM
J Pharmacol Exp Ther; 1998 Aug; 286(2):727-35. PubMed ID: 9694927
[TBL] [Abstract][Full Text] [Related]
29. Saxitoxin is a gating modifier of HERG K+ channels.
Wang J; Salata JJ; Bennett PB
J Gen Physiol; 2003 Jun; 121(6):583-98. PubMed ID: 12771193
[TBL] [Abstract][Full Text] [Related]
30. Blockade of the HERG human cardiac K(+) channel by the antidepressant drug amitriptyline.
Jo SH; Youm JB; Lee CO; Earm YE; Ho WK
Br J Pharmacol; 2000 Apr; 129(7):1474-80. PubMed ID: 10742304
[TBL] [Abstract][Full Text] [Related]
31. Differential effects of amino-terminal distal and proximal domains in the regulation of human erg K(+) channel gating.
Viloria CG; Barros F; Giráldez T; Gómez-Varela D; de la Peña P
Biophys J; 2000 Jul; 79(1):231-46. PubMed ID: 10866950
[TBL] [Abstract][Full Text] [Related]
32. The antipsychotic agent sertindole is a high affinity antagonist of the human cardiac potassium channel HERG.
Rampe D; Murawsky MK; Grau J; Lewis EW
J Pharmacol Exp Ther; 1998 Aug; 286(2):788-93. PubMed ID: 9694935
[TBL] [Abstract][Full Text] [Related]
33. Block of HERG-carried K+ currents by the new repolarization delaying agent H 345/52.
Amos GJ; Jacobson I; Duker G; Carlsson L
J Cardiovasc Electrophysiol; 2003 Jun; 14(6):651-8. PubMed ID: 12875428
[TBL] [Abstract][Full Text] [Related]
34. Altered gating of HERG potassium channels by cobalt and lanthanum.
Sanchez-Chapula JA; Sanguinetti MC
Pflugers Arch; 2000 Jun; 440(2):264-74. PubMed ID: 10898527
[TBL] [Abstract][Full Text] [Related]
35. Effects of irbesartan on cloned potassium channels involved in human cardiac repolarization.
Moreno I; Caballero R; González T; Arias C; Valenzuela C; Iriepa I; Gálvez E; Tamargo J; Delpón E
J Pharmacol Exp Ther; 2003 Feb; 304(2):862-73. PubMed ID: 12538844
[TBL] [Abstract][Full Text] [Related]
36. High affinity open channel block by dofetilide of HERG expressed in a human cell line.
Snyders DJ; Chaudhary A
Mol Pharmacol; 1996 Jun; 49(6):949-55. PubMed ID: 8649354
[TBL] [Abstract][Full Text] [Related]
37. Modulation of HERG current and herg gene expression during retinoic acid treatment of human neuroblastoma cells: potentiating effects of BDNF.
Arcangeli A; Rosati B; Crociani O; Cherubini A; Fontana L; Passani B; Wanke E; Olivotto M
J Neurobiol; 1999 Aug; 40(2):214-25. PubMed ID: 10413451
[TBL] [Abstract][Full Text] [Related]
38. N-linked glycosylation sites determine HERG channel surface membrane expression.
Petrecca K; Atanasiu R; Akhavan A; Shrier A
J Physiol; 1999 Feb; 515 ( Pt 1)(Pt 1):41-8. PubMed ID: 9925876
[TBL] [Abstract][Full Text] [Related]
39. Influence of amino-terminal structures on kinetic transitions between several closed and open states in human erg K+ channels.
Gómez-Varela D; de la Peña P; García J; Giráldez T; Barros F
J Membr Biol; 2002 May; 187(2):117-33. PubMed ID: 12029369
[TBL] [Abstract][Full Text] [Related]
40. Identification and functional characterization of a novel KCNE2 (MiRP1) mutation that alters HERG channel kinetics.
Isbrandt D; Friederich P; Solth A; Haverkamp W; Ebneth A; Borggrefe M; Funke H; Sauter K; Breithardt G; Pongs O; Schulze-Bahr E
J Mol Med (Berl); 2002 Aug; 80(8):524-32. PubMed ID: 12185453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
